Clinical Trials
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-9208
Health Status and Quality of Life (QL) in Patients with Early Stage Hodgkin's Disease: A companion study to SWOG-9133, Ancillary
Research Committee(s)
Lymphoma
Activated
04-15-1994
Closed
04-24-2000
Closed
Phase
Accrual
98%
Published
SWOG Clinical Trial Number
SWOG-9313
Phase III Comparison of Adjuvant Chemotherapy with High-Dose Cyclophosphamide plus Doxorubicin (AC) versus Sequential Doxorubicin followed by Cyclophosphamide (A’C) in High-Risk Breast Cancer Patients with 0 - 3 Positive Nodes (Intergroup)
Research Committee(s)
Breast Cancer
Activated
03-15-1994
Closed
05-01-1997
Closed
Phase
Accrual
98%
Published
SWOG Clinical Trial Number
SWOG-9304 (INT-0144)
Postoperative Evaluation of 5-FU by Bolus Injection versus 5-FU by Prolonged Venous Infusion Prior to and Following Combined Prolonged Venous Infusion Plus Pelvic XRT Versus Bolus 5-FU Plus Leucovorin Plus Levamisole Prior to and Following Combined Pelvic XRT in Patients with Rectal Cancer, Phase III, Intergroup
Research Committee(s)
Gastrointestinal Cancer
Activated
03-01-1994
Closed
08-01-2000
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9339
Evaluation of Topotecan in Esophageal Carcinoma, Phase II
Research Committee(s)
Gastrointestinal Cancer
Activated
03-01-1994
Closed
12-15-1995
Closed
Phase
Accrual
90%
Published
SWOG Clinical Trial Number
SWOG-9228
Evaluation of Interleukin-4 (IL-4) in Disseminated Malignant Melanoma, Phase II
Research Committee(s)
Melanoma
Activated
03-01-1994
Closed
09-01-1995
Closed
Phase
Accrual
90%
Published
SWOG Clinical Trial Number
SWOG-9321
Standard Dose Versus Myeloablative Therapy For Previously Untreated Symptomatic Multiple Myeloma
Research Committee(s)
Myeloma
Activated
01-15-1994
Closed
09-15-2000
Closed
Phase
Accrual
75%
Published
SWOG Clinical Trial Number
SWOG-9305 (CALGB-8984)
Evaluation of Topotecan in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck, Phase II
Research Committee(s)
Head and Neck Cancer
Activated
01-15-1994
Closed
05-15-1995
Closed
Phase
Accrual
96%
Published
SWOG Clinical Trial Number
SWOG-9235
Phase II Trial of Casodex in Advanced Prostate Cancer Patients Who Failed Conventional Hormonal Manipulation
Research Committee(s)
Genitourinary Cancer
Activated
12-15-1993
Closed
06-01-1994
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9109
Neoadjuvant Zoladex and Flutamide in Bulky and Non-Bulky Clinical Stage C Carcinoma of the Prostate, Phase II
Research Committee(s)
Genitourinary Cancer
Activated
12-01-1993
Closed
10-15-1996
Closed
Phase
Accrual
98%
Published
SWOG Clinical Trial Number
SWOG-9308
Randomized Trial Comparing Cisplatin With Cisplatin Plus Intravenous Navelbine® in the Treatment of Previously Untreated, Stage IV Non-Small Cell Lung Cancer Patients
Research Committee(s)
Lung Cancer
Activated
10-15-1993
Closed
06-01-1995
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9217
Chemoprevention of Prostate Cancer with Finasteride (Proscar®), Phase III, Intergroup (PCPT)
Activated
10-13-1993
Closed
12-06-1996
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9223
Evaluation of Alpha Interferon/All Trans-Retinoic Acid in Disseminated Malignant Melanoma, Phase II
Research Committee(s)
Melanoma
Activated
10-01-1993
Closed
08-15-1995
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9312
Phase II Evaluation of Cisplatin + 5-FU + Radiation Therapy in Patients with Locally Advanced/Inoperable Bladder Cancer
Research Committee(s)
Genitourinary Cancer
Activated
10-01-1993
Closed
04-01-1998
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9142
Evaluation of Gallium Nitrate Continuous Infusion Therapy for Advanced Bladder Carcinoma
Research Committee(s)
Genitourinary Cancer
Activated
09-15-1993
Closed
02-01-1996
Closed
Phase
Accrual
91%
Published
SWOG Clinical Trial Number
SWOG-9314
Biologic Factors Predicting Response to Tamoxifen in Patients Registered to SWOG-8228, Ancillary
Research Committee(s)
Breast Cancer
Activated
09-01-1993
Closed
12-15-1995
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9326
Phase II Trial of Altretamine for Consolidation of Clinical Complete Response in Patients with Stage III Epithelial Ovarian Cancer
Research Committee(s)
Gynecologic Cancer
Activated
09-01-1993
Closed
07-01-1997
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9241
Evaluation of Topotecan in Colorectal Cancer, Phase II
Research Committee(s)
Gastrointestinal Cancer
Activated
07-15-1993
Closed
11-15-1994
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-9023
Cytogenetic and Flow Cytometric Analysis of Solid Tumors: Renal Cell Carcinoma: A Companion Study to SWOG-8949
Research Committee(s)
Genitourinary Cancer
Activated
07-01-1993
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9307
Extended Administration of Oral Etoposide And Oral Cyclophosphamide for the Treatment of Poor Prognosis Extensive Disease Small Cell Lung Cancer, Phase II Pilot
Research Committee(s)
Lung Cancer
Activated
07-01-1993
Closed
06-01-1996
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9106